Early-stage Parkinson's Disease
Neurology·MeSH: Parkinson Disease
Prevalence
151.4 / 100K
Incidence
17.9 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| ucb0599 | GT Biopharma, Inc. (GTBP) |
Frequently asked questions
How many drugs are in development for Early-stage Parkinson's Disease?
BioSniper tracks 1 drug in development for Early-stage Parkinson's Disease across 1 company.
How many clinical trials target Early-stage Parkinson's Disease?
There are 1 clinical trial targeting Early-stage Parkinson's Disease tracked by BioSniper.
What is the prevalence of Early-stage Parkinson's Disease?
The estimated prevalence of Early-stage Parkinson's Disease is approximately 151.4 per 100,000 population.
Deep-dive into Early-stage Parkinson's Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis